Financial Markets
Real Estate
Local listed Company
Overseas-listed Company
Foreign Company
Industrial Parks

Financial Market
 Search News  Or
Tianjin Chase Sun Pharm expects 160% surge in H1 net profit

Jul. 6, 2012 (China Knowledge) - Tianjin Chase Sun Pharmaceutical Co Ltd<300026> has announced that it expected its net profit to soar between130% and 160% YoY in the first half of this year.

The company said in a statement filed with the Shenzhen Stock Exchange that its net profit was estimated at between RMB 99.22 million and RMB 112 million in the first six months.

The company attributed the strong growth in net profit to a significant increase in revenue from its major products and higher profit contribution from subsidiary Beijing Kangrentang Pharmaceutical Co.

In the first quarter of this year, the company's net profit was RMB 38.01 million, up 95.85% from the same period of last year. Core business revenue surged 52.75% YoY to RMB 160.42 million in the period.

Add this     
Copyright © "2015"

Send feedback or comments to:

For more news, financial weekly reports, business guides to China, Market Research Reports and other premium information, subscribe to China Knowledge today

To access our page on Bloomberg, type CKFI (GO)

 Our Professional Services


 News Archive
About Us | CSR | Media Center | E-Newsletter | E-Store | Contact Us | Feedback | Sitemap | Privacy Policy | Terms of Use  

           Copyright © 2014 China Knowledge Online. All Rights Reserved